Page last updated: 2024-08-21

pyrazines and Amyloid Deposits

pyrazines has been researched along with Amyloid Deposits in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aston-Mourney, K; Goldstein, LC; Hull, RL; Meier, DT; Samarasekera, T; Subramanian, SL; Zraika, S1
Isayama, R; Mizutani, R; Nakagawa, M; Shiga, K; Shimazaki, C; Tokuda, T1
Bauer, S; Berger, R; Bittner, T; Boländer, A; Burgold, S; Czech, C; Goetschy, V; Herms, J; Heyny-von Haußen, R; Hilger, I; Hölzer, J; Kieser, D; Knust, H; Mall, G; Schmidt, B; Schön, C; Voss, C1

Other Studies

3 other study(ies) available for pyrazines and Amyloid Deposits

ArticleYear
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice.
    American journal of physiology. Endocrinology and metabolism, 2013, Aug-15, Volume: 305, Issue:4

    Topics: Animals; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Hemizygote; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Male; Metformin; Mice; Mice, Transgenic; Pancreas; Pancreatic Neoplasms; Pancreatitis; Plaque, Amyloid; Pyrazines; Random Allocation; Recombinant Proteins; Sitagliptin Phosphate; Time Factors; Triazoles

2013
Amyloid myopathy: a therapeutic trial for the rare and underdiagnosed myopathy with bortezomib.
    Journal of neurology, 2010, Volume: 257, Issue:12

    Topics: Aged; Boronic Acids; Bortezomib; Female; Humans; Multiple Myeloma; Muscular Diseases; Plaque, Amyloid; Protease Inhibitors; Pyrazines

2010
Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils and β-amyloid plaques in Alzheimer's disease models.
    Journal of medicinal chemistry, 2012, Nov-08, Volume: 55, Issue:21

    Topics: Aged, 80 and over; Alzheimer Disease; Animals; Biological Availability; Brain; Fluorescent Dyes; Humans; Mice; Mice, Transgenic; Microscopy, Fluorescence; Olfactory Mucosa; Organ Specificity; Permeability; Plaque, Amyloid; Pyrazines; Pyridazines; Pyrimidines; Stereoisomerism; Structure-Activity Relationship; tau Proteins

2012